SCHEDULE 13D/A Filed 2026-07-31 Event 2026-07-29 SEC 0001999371-26-016673 →

TPG GP A, LLC → TPG Twin Brook Capital Income Fund

Stake: — Shares: 23,342,573.94 Class: Class I common shares of beneficial interest, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

18 filings by this filer

17 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on TPG Twin Brook Capital Income Fund

Filed	Form	Filer	Stake	Shares
2026-07-01	SCHEDULE 13D/A	TPG GP A, LLC	—	21,349,053.96	view →
2024-07-02	SC	AG Twin Brook Capital Income Fund	—	—	view →

Other Filings by TPG GP A, LLC

Filed	Form	Issuer	Stake	Shares
2026-07-01	SCHEDULE 13D/A	TPG Twin Brook Capital Income Fund	—	21,349,053.96	view →
2026-05-26	SCHEDULE 13D/A	Life Time Group Holdings, Inc. LTH	—	9,476,069	view →
2026-05-18	SCHEDULE 13D/A	TPG Inc. TPGXL	—	217,809,708	view →
2026-05-18	SCHEDULE 13D	Odyssey Therapeutics, Inc. ODTX	7.80%	3,690,146	view →
2026-04-24	SCHEDULE 13D	ACHIEVE LIFE SCIENCES, INC. ACHV	12.60%	13,755,160	view →
2026-01-13	SCHEDULE	Anywhere Real Estate Inc.	—	—	view →
2025-09-15	SCHEDULE	Life Time Group Holdings, Inc. LTH	8.10%	17,830,652	view →
2025-02-25	SCHEDULE	TPG Inc. TPGXL	68.50%	248,441,034	view →
2024-11-18	SC	TPG Inc. TPGXL	—	—	view →
2023-07-14	SC	Super League Gaming, Inc. SLE	—	—	view →
2022-01-19	SC	Amneal Pharmaceuticals, Inc. AMRX	—	—	view →
2022-01-18	SC	Allogene Therapeutics, Inc. ALLO	—	—	view →
2022-01-18	SC	Rallybio Corp RLYB	—	—	view →
2022-01-18	SC	SUPERIOR INDUSTRIES INTERNATIONAL INC	—	—	view →
2022-01-18	SC	Life Time Group Holdings, Inc. LTH	—	—	view →
2022-01-18	SC	Fusion Pharmaceuticals Inc.	—	—	view →
2022-01-18	SC	Entasis Therapeutics Holdings Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →